SPDL1 and non-small cell lung carcinoma: Similarly, Vecchiarelli et al. demonstrated in their study that sPD-L1 levels were elevated in NSCLC patients who received chemotherapy, but not in those who received treatments like TKIs or immunotherapy (39).